Skip to content

Study of Haridra, Gomutra Arka, and Jalaukavacharanama in the management of Kitibha (Psoriasis)

A Comparative clinical evaluation of Haridra, Gomutra Arka, and Jalaukavacharanama in the management of Kitibha (Psoriasis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038973
Enrollment
60
Registered
2021-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: 1.HaridraChurna 2.Gomutra Arka 3.Jalaukacharanam : 1.HaridraChurna3 gm twice a day (Shaman Chikitsa) 2.GomutraArka10 ml twice a day (Shaman Chikitsa) 3.Jalaukacharanam once in a week f

Sponsors

Department of Kayachikitsa Faculty of Ayurveda Institute of Medical Sciences
Lead Sponsor
Department of Panchkarma Faculty of Ayurveda Institute of Medical Sciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Age group between 18-60 years. 2. Classical Features & Diagnosed cases of psoriasis. 3. Patients willing to participate in above mentioned trial and giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Age group less than 18 years and more than 60 years. 2. Psoriatic patients with other systemic disease like; Hypertension, Anemia, Diabetes Mellitus, Asthma, Jaundice, Cardiac diseases, HIV etc. 3. Patient has donated more than 500ml of blood within last month. 4. Patient has suffered a serious bacterial infection. 5. Pregnant and lactating women. 6. Patients with psoriatic complications 7. Patients taking other drugs for the treatment of psoriasis

Design outcomes

Primary

MeasureTime frame
1.CBC 2.ESR 3.RBS 4.TNF α 5.CRPTimepoint: three months with 3 follow ups of one month each.

Secondary

MeasureTime frame
1.To evaluate effect of Haridra 2.To evaluate effect of GomutraArka 3.To evaluate effect of Raktamokshan Timepoint: three months with 3 follow ups of one month each.

Countries

India

Contacts

Public ContactProf OP Singh

Banaras Hindu University

singhopbhu@gmail.com9415818732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026